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Mycobacterium ulcerans is the causative agent of a tropical
skin disease called Buruli ulcer (18), which has recently been
recognized as an emerging infection in West Africa (12). Buruli ulcer patients present with indolent, necrotizing ulcerative
lesions. The ulcers are characterized by extensive necrosis of
the skin and underlying fat. Erythema and focal necrosis, including vascular erosion, are also present. In contrast to other
pathogenic mycobacterial diseases such as tuberculosis, there
is little evidence of an early acute inflammatory response to the
infection, and the bacteria are primarily extracellular. Although the lesions may be quite extensive, covering up to 15%
of a patient’s skin surface, they are relatively painless.
We have recently purified and characterized a polyketide
toxin from M. ulcerans and termed this mycolactone (10).
When added to the mouse fibroblast cell line L929, the toxin
causes 90 to 100% of the adherent cells to undergo cytoskeletal
rearrangement, subsequently rounding up and detaching from
the tissue culture plate within 24 to 36 h of treatment. This has
been termed the cytopathic effect (CPE) (9, 15, 25). The toxin
also causes an arrest in the G0/G1 phase of the cell cycle within
48 h (9, 10). More importantly, mycolactone, when injected
intradermally into guinea pigs, is capable of causing a lesion
similar to that produced by whole organisms (10). An isogenic
mutant which does not produce the toxin is not virulent in the
guinea pig model. Taken together, these data provide strong
evidence that mycolactone plays a pivotal role in Buruli ulcer
pathogenesis.
Necrotic areas in infected guinea pig skin contain many
pyknotic nuclei, a finding suggestive of apoptosis. It is impossible to determine by hematoxylin-eosin staining whether these
cells are resident or infiltrated immune cells killed at the site of
the lesion. In addition, the mechanism of cell death is unknown. To begin to identify the mechanism underlying the

histopathology observed in the guinea pig lesions, we decided
to look closer at mechanisms of cell death, such as apoptosis.
The cell death apparent in mycolactone-induced guinea pig
lesions is at odds with the observation that mycolactone causes
growth arrest, with little reduction in viability, in L929 cells. To
address the possibility that mycolactone can induce cell death
in tissue culture cells with delayed kinetics, we extended the
length of time of the cytopathology assay. We also included a
macrophage-like cell line, J774, in our experiments to study the
possible immune regulatory functions of the toxin. J774 cells
exhibit a similar cytopathology to that of L929 cells. A total of
90 to 100% of cells exhibit cytoskeletal rearrangements within
24 to 36 h of treatment and undergo growth arrest. In addition,
24-h pretreatment of J774 cells with toxin inhibits induction of
the proinflammatory cytokines, tumor necrosis factor alpha
(TNF-␣), and interleukin-1 (IL-1) in response to lipopolysaccharide stimulation (L. Pascopella, unpublished results).
We have used here both in vivo and in vitro studies to
determine the mechanism of cell death mediated by mycolactone. We demonstrate that apoptotic cells reside in the area of
necrosis of the guinea pig lesions infected with either M. ulcerans organisms or the toxin alone. This area of necrosis with
apoptosis increases with time, indicating that apoptosis may
play a role in Buruli ulcer pathology and, in particular, the lack
of inflammation. We also show that the toxin does cause cell
death in L929 and J774 cells, with delayed kinetics. Using
the TUNEL (terminal deoxynucleotidyltransferase-mediated
dUTP-biotin nick end labeling) reaction and genomic DNA
analysis, we show that the toxin can cause apoptosis to occur in
the two cell lines. Treating the L929 cells with a caspase inhibitor prevents apoptosis, but not cytopathology, suggesting
that apoptosis may be a secondary, rather than primary, effect
of the toxin on tissue culture cells.

* Corresponding author. Mailing address: Microscopy Branch, NIAID/
NIH, Rocky Mountain Laboratories, 903 S 4th St., Hamilton, MT
59840. Phone: (406) 363-9280. Fax: (406) 363-9371. E-mail: psmall
@niaid.nih.gov.

Eukaryotic cell culture. L929 mouse fibroblast cells (ATCC CCL1) and mouse
macrophage cells J774A.1 (ATCC TIB 67) were purchased from the American
Type Culture Collection and passaged in Dulbecco modified Eagle medium
supplemented with 10% heat-inactivated fetal calf serum (Gibco BRL, Grand
Island, N.Y.).

MATERIALS AND METHODS
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Mycobacterium ulcerans is the causative agent of Buruli ulcer, a tropical ulcerative skin disease. One of the
most intriguing aspects of this disease is the presence of extensive tissue damage in the absence of an acute
inflammatory response. We recently purified and characterized a macrolide toxin, mycolactone, from M.
ulcerans. Injection of this molecule into guinea pig skin reproduced cell death and lack of acute inflammatory
response similar to that seen following the injection of viable bacteria. We also showed that mycolactone causes
a cytopathic effect on mouse fibroblast L929 cells that is characterized by cytoskeletal rearrangements and
growth arrest within 48 h. However, these results could not account for the extensive cell death which occurs
in Buruli ulcer. The results presented here demonstrate that L929 and J774 mouse macrophage cells die via
apoptosis after 3 to 5 days of exposure to mycolactone. Treatment of cells with a pan-caspase inhibitor can
inhibit mycolactone-induced apoptosis. We demonstrate that injection of mycolactone into guinea pig skin
results in cell death via apoptosis and that the extent of apoptosis increases as the lesion progresses. These results
may help to explain why tissue damage in Buruli ulcer is not accompanied by an acute inflammatory response.
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Preparation of mycolactone. M. ulcerans 1615 (ATCC 35840) cells were passaged as described elsewhere (9). Mycolactone was prepared as described previously (10). Briefly, late-exponential-phase M. ulcerans bacteria were harvested
and extracted with chloroform-methanol (2:1 [vol/vol]) for 2 h at room temperature. The cell debris was separated from the organic phase by centrifugation,
and a Folch extraction was performed by the addition of 0.2 volumes of water.
The organic phase was dried down and resuspended in a small volume of ice-cold
acetone. Mycolactone was purified from the acetone-soluble fraction on a preparative thin-layer chromatography plate (Whatman Pk6F Silica Gel 60; Alltech,
Deerfield, Ill.) developed in chloroform-methanol-water (90:10:1 [vol/vol]). Mycolactone runs at an Rf of 0.23 in this solvent system. Mycolactone was eluted
from the silica plate in running buffer and weighed, and the effective dose was
determined (see below) (9).
Guinea pig skin model of infection. Hartley female guinea pigs were prepared
for intradermal injection by shaving the backs of the animals and anesthetizing
them. M. ulcerans bacteria was used at an inoculum of 107 (confirmed by viable
plate counting). Bacteria were passed five times through a 25-gauge needle to
approximate a uniform suspension. Mycolactone was air dried, resolubilized in a
small amount of ethanol, and diluted in mycobacterial medium (Middlebrook
7H9 with OADC supplement). As a negative control, mycobacterial medium was
injected. Injections were done with final volumes of 100 l. All animal experiments were conducted according to the guidelines of the Animal Care and Use
Committee at Rocky Mountain Laboratories. Guinea pigs were observed daily
for signs of gross pathology and were sacrificed at days 2, 8, and 22 postinjection.
Lesions were excised and fixed for 24 h in 3.7% formaldehyde. Samples were
embedded in paraffin, cut into 4-m sections, and stained with hematoxylineosin.
TUNEL reaction on guinea pig sections. Paraffin-embedded guinea pig sections were dewaxed with xylenes and rehydrated through an ethanol series.
TUNEL reactions were performed with the In Situ Cell Death Detection POD
Kit (Boehringer Mannheim, Indianapolis, Ind.). The sections were treated with
10 g of proteinase K (Sigma) per ml (15 min at room temperature); endogenous
peroxidase was then blocked with 0.3% hydrogen peroxide-phosphate-buffered
saline (PBS) (30 min at room temperature) and permeabilized with 0.1% Triton
X-100 (2 min on ice). The TUNEL reaction proceeded for 60 min at 37°C with
CO2. After a washing with PBS, the slides were incubated with the ConverterPOD at a 1:2 dilution in a Tris-NaCl buffer (30 min at 37°C with 5% CO2). For
diaminobenzidene (DAB) detection, the slides were incubated with DAB substrate (10 min at room temperature). After staining with hematoxylin, the slides
were dehydrated and mounted. For negative controls, the TUNEL reaction was
performed on mycobacterial-medium-injected guinea pig skin sections and on M.
ulcerans- and mycolactone-treated sections without terminal transferase enzyme.
Cytotoxicity assay. L929 and J774 cells were plated at 2 ⫻ 104 in 24-well tissue
culture plates and allowed to adhere overnight at 37°C with CO2. The next day,
mycolactone was dissolved in ethanol and diluted in tissue culture media to the
appropriate concentration and added to wells. As a control, ethanol was diluted

similarly in tissue culture medium and added to the wells. At the indicated times,
triplicate wells of each concentration of mycolactone or control cells were harvested by removing the supernatant, washing with PBS, and removing the adherent cells with trypsin followed by a PBS wash. Adherent and nonadherent
cells were pooled and tested for presence of dead cells by ethidium homodimer
uptake with the Live/Dead Viability/Cytoxicity Kit (Molecular Probes, Inc., Eugene, Oreg.). Five fields of stained cells were visualized on a Bio-Rad MRC 1000
laser confocal microscope. The percent dead and standard error of the mean
values were calculated by using StatView 4.51 software (Abacus Concepts).
TUNEL reaction on L929 and J774 cells. Cells were plated and allowed to
adhere overnight. The next day, 300 ng of mycolactone (or an equivalent amount
of ethanol diluted in tissue culture media for the negative control) was added,
and both adherent and nonadherent cells were harvested and pooled together at
the indicated times. The TUNEL reaction was performed by using the Promega
Cell Death kit (Promega, Madison, Wis.). Briefly, the cells were fixed with 4%
paraformaldehyde-PBS (20 min at 4°C). After a PBS wash, the cells were permeabilized with 0.2% Triton X-100–PBS, and the TUNEL reaction proceeded at
37°C with 5% CO2. The reaction was stopped by washing the cells in 2⫻ SSC (1⫻
SSC is 0.15 M NaCl plus 0.015 M sodium citrate). The percentage of TUNELpositive cells was determined by counting fluorescent cells in at least five fields.
Fluorescence and phase pictures were taken on a Nikon Eclipse TE3000 inverted
microscope with an Epi-fluorescence attachment (Nikon, Inc., Melville, N.Y.).
DNA fragmentation assay. In the DNA fragmentation assay, 106 L929 or J774
cells were plated and allowed to adhere overnight at 37°C with 5% CO2. The next
day, 300 ng of mycolactone (or an equivalent amount of ethanol diluted in tissue
culture medium for control cells) per ml was added. At the indicated times,
adherent and nonadherent cells were harvested, combined, washed with PBS,
and lysed in 0.4 ml of lysis buffer (20 mM Tris, pH 8.0; 4 mM EDTA; 0.4% Triton
X-100; 20 g of proteinase K per ml; for 20 min at room temperature). Cell
debris was separated by centrifugation, and the lysate was extracted with phenolchloroform-isoamyl alcohol (25:24:1 [vol/vol]) twice and ethanol precipitated.
The DNA pellet was resuspended in TE plus 10 g RNase A (30 min at 37°C)
per ml. DNA was run on a 1.5% agarose gel, stained with ethidium bromide, and
photographed. Control cells were harvested at day 5.
Caspase inhibitor assay. Mycolactone or (ethanol diluted in tissue culture
medium for control cells) was added to L929 cells at 300 ng/ml. Boc-Asp-(Ome)fluoromethylketone (B-D-FMK) (Enzyme Systems Products, Livermore, Calif.),
a general inhibitor of caspases, was resuspended in dimethyl sulfoxide (DMSO)
at 100 mM. At the same time as the addition of mycolactone, B-D-FMK was
added at 1 M. Control cells were treated with the same percentage of DMSO
(0.001%). Due to the length of the assay and the short half-life of B-D-FMK, the
caspase inhibitor was re-added every day. Adherent and nonadherent cells were
harvested at each time point, and the TUNEL reaction was performed as described above. Cells were observed microscopically each day and scored as CPE
positive when 90 to 100% of cells were rounded and detached. In preliminary
experiments, concentrations of B-D-FMK were titrated; 1 M was the most
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FIG. 1. Detection of apoptosis in M. ulcerans-infected guinea pig lesions and media controls. The TUNEL reaction was performed, detected by use of DAB, and
counterstained with hematoxylin as described in Materials and Methods. A to C, negative control section injected with mycobacterial medium; D to F, M.
ulcerans-injected section (8 days postinjection). A and D, ⫻83; B, C, E, and F, ⫻332. Panels A, B, D, and E are hematoxylin-eosin-stained sections; panels C and F
are TUNEL sections. Arrows point to the blood vessels; muscle cells (m) are also indicated.
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effective concentration for inhibiting apoptosis without causing toxicity to L929
cells (data not shown).

RESULTS
M. ulcerans organisms and mycolactone cause apoptosis in
guinea pig skin. The extensive tissue destruction and presence
of cells with pyknotic nuclei present in M. ulcerans-infected
lesions suggests that apoptosis may be relevant to the pathogenesis of M. ulcerans. We performed the TUNEL assay on M.
ulcerans-infected guinea pig sections 8 days postinjection and
found TUNEL-positive nuclei throughout the section (Fig.
1F). An area of early adipocyte destruction, edema, and some
vascular disruption could be seen (Fig. 1D to F). As a negative
control, mycobacterial medium-treated guinea pig skin was
assayed by the TUNEL reaction and very few, if any, TUNELpositive cells were detected (Fig. 1C). As a second negative
control, the TUNEL reaction was also performed on M. ulcerans- and mycolactone-induced lesions in the absence of terminal transferase enzyme, and no positive nuclei were detected
(data not shown), indicating that the TUNEL-positive reactions were not due to endogenous peroxidase activity. Next, we
performed TUNEL assays on tissue sections from mycolactone-treated guinea pig lesions at different time points postinoculation. Controls were as shown and described in Fig. 1.
Guinea pig lesions induced by 100 g of mycolactone at 2, 8, or

22 days postinoculation (p.i.) were analyzed (10). Apoptotic
cells were present in the necrotic areas at all timepoints (Fig.
2), and the area of apoptosis increased over time as the size of
the lesion and extent of destruction grew. At all time points,
the region of apoptosis was centered around the point of injection, indicating that the toxin was acting locally to mediate
the destruction and apoptosis. At 2 days p.i., tissue destruction
was in its early stages (Fig. 2A to C). Apoptotic endothelial
cells were present around apparently intact blood vessels (Fig.
2C). Infiltrated cells, possibly monocytes, were also apoptotic
(Fig. 2C). At 8 days p.i., the tissue destruction was more apparent. Necrosis was apparent in the adipose, muscle, and
underlying areas. Blood vessels show leakage into the muscle
layer, presumably from microhemorrhages (Fig. 2D to F). Apoptosis was present throughout the necrotic area. The area of
edema between adipocytes and muscle with primarily apoptotic cells can be seen (Fig. 2F). At 22 days p.i., tissue destruction
was massive (Fig. 2G to I). Edema and calcification were apparent, as well as disrupted blood vessels. All nuclei surrounding the blood vessel were apoptotic (Fig. 2I). The toxin-induced lesions progressed much more rapidly than the
bacterium-induced lesions and were more localized around the
point of inoculation. There also appeared to be more TUNELpositive cells in the mycolactone-treated lesions than in the M.
ulcerans-infected lesions. These observations can be explained
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FIG. 2. Detection of apoptosis in mycolactone-induced guinea pig lesions. The TUNEL reaction was performed, detected by use of DAB, and counterstained with
hematoxylin-eosin as described in Materials and Methods. The mycobacterial-medium control is shown in panels A to C of Fig. 1. A to C, 2 days p.i.; D to F, 8 days
p.i; G to I, 22 days p.i. Magnifications: A, D, and G, ⫻83; B, C, E, F, H, and I, ⫻332. Panels A, B, D, E, G, and H are hematoxylin-eosin-stained sections; panels C,
F, and I are TUNEL sections. Arrows point to blood vessels; muscle (m), adipocytes (a), and calcification (c) are also indicated.
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by a more dramatic, although physiological, response to the
purified toxin.
Mycolactone-induced cell death of L929 and J774 cells. Several characterized bacterial toxins are capable of causing cell
cycle arrest followed by delayed cell death (6, 31), and we
hypothesized that mycolactone may also cause a delayed cell
death on L929 cells. We treated L929 cells with increasing
concentrations of mycolactone and assayed for cell death by
ethidium homodimer uptake. A wide range of concentrations
of mycolactone (3 ng/ml to 3 g/ml, which corresponds to
approximately 4 nM to 4 M) caused significant cell death of

L929 cells after 3 days of treatment (Fig. 3A). Concentrations
at or below 300 pg/ml had no effect on cell viability. It is
important to note that all concentrations of mycolactone which
caused cell death also caused an identical CPE (90 to 100% of
cells rounding and growth arrest within 48 h).
The lack of an acute inflammatory response and the paucity
of peripheral mononuclear cells in M. ulcerans- and mycolactone-induced lesions raises several interesting hypotheses. The
toxin may directly kill macrophages, or it may inhibit their
chemotaxis toward the lesion. To address the former possibility, we tested a mouse macrophage cell line J774 to determine
whether mycolactone mediates cell death in a manner similar
to fibroblasts. J774 cells, like L929 cells, displayed similar morphological changes and dose dependence, although the kinetics of cell death were accelerated in comparison (Fig. 3B). Like
L929 cells, the J774 line was affected at concentrations above
300 pg/ml. All concentrations of mycolactone which caused cell
death in J774 cells also caused identical CPE, as in the L929
cells.
TUNEL assay and genomic DNA analysis. To determine
whether mycolactone causes death by apoptosis, we assayed
mycolactone-treated L929 and J774 cells for DNA fragmentation by TUNEL and gel electrophoresis assays. At 3 days after
treatment, L929 cells reacted positively in TUNEL assays (Fig.
4B). J774 cells reacted positively after 2 days treatment with
mycolactone (Fig. 4D). Control cells were negative by the
TUNEL assay. A kinetic analysis of the percentage of cells
positive by this assay indicated that apoptosis occurred with
slightly different kinetics in the two cell lines, occurring after 2
days of treatment in the macrophage cell line as opposed to
after 3 days of treatment for the fibroblasts (Fig. 5).
The ability of mycolactone to induce apoptotic-like DNA
fragmentation was confirmed by extraction of whole genomic
DNA from treated cells and electrophoresis on agarose gels.
L929 cells showed the characteristic DNA laddering of apoptotic cells after 3 days of treatment (Fig. 6). J774 DNA was
analyzed at day 2 and day 3 posttreatment with mycolactone,
corresponding to the days with the highest percentage of
TUNEL-positive cells. We were unable to detect laddering of
J774 DNA with this assay, even though the experiment was
repeated several times. Instead, the DNA appeared degraded
compared to the control (ethanol-treated) cells (Fig. 6).
Inhibition of apoptosis in L929 cells. The lag time between
the CPE (cytoskeletal rearrangement) and apoptosis led us to
ask whether the two events are interdependent. We hypothesized that, by inhibiting apoptosis, we may alter either the
kinetics or the severity of the CPE.
Inhibitors of the IL-1␤-converting enzyme family of caspases
have been shown to inhibit apoptosis (20, 27, 32). A pancaspase inhibitor, B-D-FMK, was used to inhibit apoptosis of
mycolactone-treated L929 cells. B-D-FMK was added to L929
cells at the same time as mycolactone and re-added daily (due
to inactivation by endogenous cysteine proteases). Cells were
analyzed microscopically for CPE as defined in Materials and
Methods and then harvested and processed for TUNEL reaction. L929 cells treated with mycolactone and B-D-FMK show
normal CPE, but B-D-FMK inhibits progression to apoptosis
compared to the mycolactone-treated L929 cells. B-D-FMK
treatment alone caused no CPE and did not induce apoptosis
(Fig. 7). We then asked whether inhibition of apoptosis by
B-D-FMK would change the cell death phenotype by assaying
for ethidium homodimer uptake. There was no difference in
either the kinetics of cell death or the percentage of dead cells
regardless of whether or not B-D-FMK was added to the mycolactone-treated cells (data not shown). This finding indicates
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FIG. 3. Mycolactone-mediated cell death of L929 and J774 cells. (A) Cytoxicity on L929 cells. L929 cells were treated with mycolactone at 30 pg/ml (hatched
squares), 300 pg/ml (open triangles), 3 ng/ml (hatched diamonds), 30 ng/ml
(open diamonds), 300 ng/ml (hatched circles), 3 g/ml (open circles), or ethanol
alone (open squares). (B) Cytoxicity on J774 cells. J774 cells were treated with
mycolactone at 300 pg/ml (open triangles), 30 ng/ml (open diamonds), 3 g/ml
(open circles), or ethanol alone (open squares). Cell death was measured by
ethidium homodimer uptake as described in Materials and Methods.
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that if apoptosis is inhibited, the mycolactone-treated cells die
by necrosis.
DISCUSSION
Previous work from our laboratory demonstrated that the M.
ulcerans polyketide toxin, mycolactone, causes Buruli ulcerlike lesions in a guinea pig model of infection (10, 25). These
lesions are characterized by extensive cell damage with many
cells containing pyknotic nuclei. Mycolactone also causes a
CPE on L929 cells within 48 h of treatment (defined as 90 to
100% of cells exhibiting cytoskeleton rearrangements and
growth arrest), with minimal loss of viability after 48 h. To
resolve the apparent paradox of the two phenotypes and to
begin to define the mechanism underlying the histopathology,
we looked at cell death in both systems.
To determine the relevance of apoptosis to pathology, we
performed TUNEL assays on M. ulcerans- and mycolactoneinduced guinea pig lesions and found that apoptotic cells were
present in the lesions. By studying mycolactone-induced lesions over time postinjection, it was apparent that the area of
apoptosis increased over time as the size of the lesion increased. Not all pyknotic nuclei were TUNEL positive. One
explanation for this finding is that not all cell death is apoptosis
mediated. An alternative hypothesis is that apoptosis is the
primary cause of cell death but that at any given time point not
all cells in the lesion are TUNEL positive. Due to the dearth of
guinea pig cell-specific markers, we have not definitely identified affected cells in the lesions.
We have demonstrated here that longer exposure to the
toxin causes cell death of L929 cells within 72 h across a wide
range of mycolactone concentrations. J774 cells show a similar
dose dependence of mycolactone and a cell death by 48 h,
which is slightly earlier than for the L929 cells. Using TUNEL

and DNA fragmentation assays, we showed that mycolactone
induced apoptosis coincident with cell death. It is important to
note that both the J774 and L929 cultures show 90 to 100%
cytopathicity but that the percentage of TUNEL-positive cells
over a period of days showed a maximum of 20 to 35% undergoing apoptosis. Cytopathicity and apoptosis may be two independent primary events, with apoptosis affecting only a subset
of the population. Another hypothesis is that apoptosis is a
secondary result of the CPE. Inhibition of anchorage-dependent cell spreading has been shown to trigger apoptosis (8, 24,
30), as have fungal metabolites, such as cytochalasins, which
effect actin polymerization (28, 30). By using a pan-caspase
inhibitor, we showed that mycolactone is capable of causing a
CPE in L929 cells without progression to apoptosis, demonstrating that the CPE is not dependent on apoptosis.
Although the mycolactone-treated L929 cells reproducibly
showed a strong DNA fragmentation pattern, we were unable
to demonstrate DNA fragmentation with J774 cells despite
repeated attempts. There is much information in the literature
describing apoptosis occurring without the presence of DNA
ladder formation (5, 21, 22, 29). Perhaps the window of time
that the DNA ladder would appear in J774 cells was too narrow for us to detect and, therefore, the DNA appeared intact,
as in control cells, or degraded, as in mycolactone-treated cells.
Mycolactone is a complex polyketide-derived macrolide.
Macrolides are broadly characterized into groups based on the
number of carbons present in the lactone ring (4). Mycolactone is a 12-membered ring macrolide which is the group of
macrolides containing the smallest lactone ring. Other 12membered ring macrolides include methymycin, litorin, patulolide, cladospolide, and recefeiolide (4). Although they share
a similar lactone ring size, the rest of their chemical structures
bear little resemblance to mycolactone, and no biological ac-
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FIG. 4. TUNEL reaction of L929 and J774 cells. (A and B) The TUNEL reaction was performed on L929 cells treated with mycolactone at 300 ng/ml for 3 days.
(C and D) TUNEL reaction was performed on J774 cells treated with mycolactone at 300 ng/ml for 3 days. Panels A and C are phase-contrast micrographs, and panels
B and D are fluorescence micrographs. Arrows in panels A and C identify the TUNEL-positive cells.
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The most distinctive and unique feature of M. ulcerans pathology is the presence of cell damage in the absence of an
acute inflammatory response. Why does this cell death not lead
to an acute inflammatory response? The data presented here
suggest a hypothesis for how mycolactone as a single molecule
might lead to this property. Recently, it has been shown that
mycolactone suppressed the production of inflammatory cytokines (23). These data could explain why neutrophils are absent at early time points following infection. The results presented here from both in vitro and in vivo experiments suggest

FIG. 5. Quantitation and kinetic analysis of apoptotic L929 and J774 cells.
The TUNEL reaction was performed on L929 (A) and J774 (B) cells and
quantitated as described in Materials and Methods. Symbols: 䊐, control (ethanol-treated) cells; {, mycolactone-treated cells.

tivity has been assigned for them approximating the activity we
have observed here with mycolactone. Other macrolides that
induce apoptosis in tissue culture cells include erythromycin,
bafilomycin A1, antimycin A, and ionomycin (1–3, 11, 13, 17).
The concentrations of these macrolides used to induce apoptosis are between 60 ng/ml and 6 g/ml, which is the mycolactone concentration range in which we observe similar effects.
These examples may or may not be relevant to mycolactonemediated apoptosis. Whether mycolactone exerts its effects by
any of these mechanisms is currently under investigation.
Pathogenic mycobacteria, such as M. tuberculosis, have been
shown to induce apoptosis in cultured monocytes (14, 19).
Further analysis of the mycobacterial products which may regulate apoptosis demonstrated that culture filtrate of M. tuberculosis, supernatant from heat-treated organisms, and purified
protein derivative induce apoptosis (16, 26). Whether these
extracts contain any mycolactone-like molecules is possible but
as yet unknown.

FIG. 7. B-D-FMK inhibits mycolactone-induced apoptosis. L929 cells were
treated with ethanol only (䊐), 1 M B-D-FMK only ({), mycolactone only (E),
or mycolactone plus B-D-FMK (‚). Cells were harvested at each day and processed for the TUNEL reaction.
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FIG. 6. Electrophoretic analysis of DNA from L929 and J774 cells exposed to
mycolactone. Genomic DNA was extracted from cells treated with 300 ng of
mycolactone per ml and electrophoresed on a 1.5% agarose gel. Lane M, molecular weight markers; lane C, control L929 cells (treated with ethanol and
harvested at day 5). Numbers above the lanes indicate days of treatment with
mycolactone.

INTERACTION OF M. ULCERANS TOXIN WITH HOST CELLS

VOL. 68, 2000

that cell death results from apoptosis. Apoptosis as a phenomenon is associated with a lack of inflammatory response (7). If
apoptosis is a major cause of pathology in Buruli ulcer, this
could explain why an acute inflammatory reaction does not
develop in these lesions despite extensive cell damage.
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